Xcout Intel
Vedanta Biosciences competitors & alternatives
The 12 closest competitors and alternatives to Vedanta Biosciences among life sciences companies — ranked by similarity to what Vedanta Biosciences actually does, not by market-cap band.
Subscribe to see Vedanta Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vedanta Biosciences
Vedanta Biosciences, Inc. is headquartered in Cambridge, Massachusetts, and develops groundbreaking microbiome-derived immunotherapies and therapeutics to improve patient lives.
Vedanta Biosciences at a glance
Vedanta Biosciences is a life sciences company headquartered in United States. It has raised at least $234.8M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round raised $118.5M in March 2023. Xcout tracks 4 named people at Vedanta Biosciences, including Dan Couto (Chief Operating Officer). Xcout recorded 1 job posting from Vedanta Biosciences in the last 90 days.
Vedanta Biosciences leadership
- Dan CoutoChief Operating Officer
- Tamra AdamsChief Financial Officer (Consultant)
- Paul McGovernChief Medical Officer (Consultant)
- Bernat OlleFounder, Chief Executive Officer
Vedanta Biosciences funding rounds
At least $234.8M raised across the 5 rounds on record (4 with a disclosed amount). The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $118.5M | — | |
| Series D | $68.4M | 14 named | |
| SEC Form D filing | $8M | — | |
| SEC Form D filing | $39.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Vedanta Biosciences
Xcout recorded 1 job posting from Vedanta Biosciences in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Vedanta Biosciences's hiring signals →
Top 12 Vedanta Biosciences competitors
Ranked by semantic similarity — how close each company is to Vedanta Biosciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Biotech
Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a synthetically cultured bacterial formulation currently undergoing Phase Ib evaluation. This candidate aims to mitigate the risk of gastrointestinal and bloodstream infections, alongside graft-versus-host disease, in vulnerable patients undergoing allogeneic hematopoietic stem cell or solid organ transplantation. Additionally, Seres Therapeutics is advancing SER-287 and SER-301, both in Phase Ib for ulcerative colitis, as well as SER-401, which targets metastatic melanoma, and SER-262, also directed at Clostridioides difficile infection. Seres maintains strategic alliances through licensing and collaboration agreements with entities such as Nestec Ltd. and Memorial Sloan Kettering Cancer Center. Established in 2010, the company previously operated as Seres Health, Inc. before adopting its current name in May 2015, and it maintains its principal offices in Cambridge, Massachusetts.
Biotechnology
Merida Biosciences is a privately held biotechnology company headquartered in Cambridge, Massachusetts. The company launched with significant funding to develop novel scientific platforms and therapeutic pipelines.
Biotech
Vesalius Therapeutics is a biotechnology company founded by Flagship Pioneering to redefine how common illnesses are treated. Headquartered in Cambridge, Massachusetts, the firm applies novel human data insights to drug discovery and therapeutic development.
Biotechnology
Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Biotechnology
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Biotech
Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic designed to address complicated urinary tract infections (cUTIs), including pyelonephritis, in adult patients. SPR206, an intravenously administered agent specifically developed to combat MDR Gram-negative bacterial infections in hospital environments. SPR720, an oral antibiotic targeting non-tuberculous mycobacterial (NTM) pulmonary disease. Spero Therapeutics has also forged several strategic alliances: A licensing agreement with Meiji Seika Pharma Co., Ltd. supports the ongoing development of tebipenem HBr. A separate licensing deal with Everest Medicines grants rights for the development, manufacturing, and commercialization of SPR206 across Greater China, South Korea, and various Southeast Asian nations. The company collaborates with the Bill & Melinda Gates Medical Research Institute to advance SPR720 for treating lung infections caused by Mycobacterium tuberculosis. Furthermore, a licensing agreement with Vertex Pharmaceuticals Incorporated covers patents associated with SPR720 and its active metabolite, SPR719. Founded in 2013, Spero Therapeutics maintains its corporate headquarters in Cambridge, Massachusetts.
Biotechnology
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Biotech
Pendulum Therapeutics is a biotechnology company headquartered in San Francisco, California. Founded by scientific experts, it develops next-generation microbiome products and probiotic solutions to improve metabolic health.
Similar life sciences company
GreenLight Biosciences, Inc. is a biotechnology company headquartered in Medford, Massachusetts, that develops sustainable platform solutions for various markets.
Biotech
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vedanta Biosciences and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vedanta Biosciencesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →